English | Español

Boehringer-Ingelheim
Jamie Barrand | Oct 7, 2015

Boehringer Ingelheim, BioMed X establish joint research team
+ Technology/Innovation
Daniel Daw | Sep 18, 2015

Study shows Jardiance reduces cardiovascular risks in patients with Type 2 diabetes
Jamie Barrand | Sep 18, 2015

Spriva Respimat approved by FDA for maintenance treatment of asthma

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes